PROGgeneV2 - Pan Cancer Prognostics Database





# CANCER DATASET DESCRIPTION TOTAL SAMPLES TOTAL GENES
1 ADRENAL GSE19776 GSE19776 - Adrenocortical Carcinoma Gene Expression Profiling 22 21933
2 ADRENAL GSE33371 GSE33371 - Beta-catenin status effects in human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10) 23 21212
3 ADRENAL TCGA-ACC   TCGA DATA ADRENOCORTICAL CARCINOMA 79 16907
4 BLADDER GSE13507 GSE13507 - Predictive Value of Prognosis-Related Gene Expression Study in Primary Bladder Cancer 165 24357
5 BLADDER GSE19915 GSE19915 - Subtype classification, grading, and outcome prediction of urothelial carcinomas by combined mRNA profiling and aCGH 144 2506
6 BLADDER GSE31684 GSE31684 - Combination of a novel gene expression signature with a clinical nomogram improves the prediction of survival in high-risk bladder cancer 93 21702
7 BLADDER GSE48276 GSE48276 - Gene expression profiling of urothelial carcinoma 73 20717
8 BLADDER TCGA-BLCA TCGA BLADDER CARCINOMA DATA 123 15448
9 BONE GSE21257 GSE21257 - Genome-wide gene expression profiling on pre-chemotherapy biopsies of osteosarcoma patients 53 24996
10 BRAIN GSE13041_U133 GSE13041 - Gene expression analysis of glioblastomas identifies the major molecular basis for the prognostic benefit of younger age 191 13480
11 BRAIN GSE13041_U95v2 GSE13041 - Gene expression analysis of glioblastomas identifies the major molecular basis for the prognostic benefit of younger age 49 9383
12 BRAIN GSE16011 GSE16011 - Intrinsic Gene Expression Profiles of Gliomas are a Better Predictor of Survival than Histology 262 21212
13 BRAIN GSE16581 GSE16581 - Genomic landscape of meningiomas: gene expression 67 21703
14 BRAIN GSE2817 GSE2817 - Wavelet modelling of microarray data provides chromosomal pattern of expression which predicts survival in gliomas 25 21703
15 BRAIN GSE30074 GSE30074 - Expression data from 30 medulloblastomas 30 21103
16 BRAIN GSE37418 GSE37418 - Novel mutations target distinct subgroups of medulloblastoma. 75 21703
17 BRAIN GSE42669 GSE42669 - Patient specific orthotopic glioblastoma xenograft models recapitulate the histopathology and biology of human glioblastomas in situ (gene expression) 55 21092
18 BRAIN GSE4271_U133A Molecular subclasses of high-grade glioma: prognosis, disease progression, and neurogenesis 77 13720
19 BRAIN GSE4271_U133B Molecular subclasses of high-grade glioma: prognosis, disease progression, and neurogenesis 78 10688
20 BRAIN GSE4412_U133A freij-affy-human-91666 83 13720
21 BRAIN GSE4412_U133B freij-affy-human-91666 83 10688
22 BRAIN GSE7696 GSE7696 - Glioblastoma from a homogenous cohort of patients treated within clinical trial 77 21212
23 BRAIN TCGA-GBM TCGA DATA GLIOBLASTOMA MULTIFORME 577 17813
24 BRAIN TCGA-LGG TCGA LOWER GRADE GLIOMA DATA 206 16467
25 BREAST GSE10886-GPL1390   GSE10886 - A Supervised Risk Predictor of Breast Cancer Based on Biological Subtypes 104 6378
26 BREAST GSE10893-GPL1390   GSE10893 - Basal-like Breast Cancer DNA copy number losses identify genes involved in genomic instability, response to therapy, and patient survival 149 4929
27 BREAST GSE10893-GPL887   GSE10893 - Basal-like Breast Cancer DNA copy number losses identify genes involved in genomic instability, response to therapy, and patient survival 51 10463
28 BREAST GSE11121 GSE11121 - The humoral immune system has a key prognostic impact in node-negative breast cancer 200 13480
29 BREAST GSE12093 GSE12093 - The 76-gene Signature Defines High-Risk Patients that Benefit from Adjuvant Tamoxifen Therapy 132 13476
30 BREAST GSE1379 GSE1379 - breast cancer / tamoxifen monotherapy (whole tissue tumor biopsies) 60 15369
31 BREAST GSE1456_U133A GSE1456_U133A - Gene expression of breast cancer tissue in a large population-based cohort of Swedish patients 159 13480
32 BREAST GSE1456_U133B GSE1456_U133B - Gene expression of breast cancer tissue in a large population-based cohort of Swedish patients 159 9856
33 BREAST GSE16987   GSE16987 - A new gene expression signature, the ClinicoMolecular Triad Classification, may improve prediction and prognostication of breast cancer at the time of diagnosis 146 14359
34 BREAST GSE17705 GSE17705 - Endocrine Sensitivity Index Validation Dataset 298 13480
35 BREAST GSE18229-GPL1390   GSE18229 - Phenotypic and Molecular Characterization of the Claudin-low Intrinsic Subtype of Breast Cancer 160 4844
36 BREAST GSE18229-GPL887   GSE18229 - Phenotypic and Molecular Characterization of the Claudin-low Intrinsic Subtype of Breast Cancer 53 10460
37 BREAST GSE19536-GPL6480   GSE19536 - Molecular Characterization of Breast Cancer Subtypes Derived from Joint Analysis of High Throughput miRNA and mRNA Data 113 16505
38 BREAST GSE19615 GSE19615 - Integrated genomic and function characterization of the 8q22 gain 115 21212
39 BREAST GSE19783-GPL6480   GSE19783 - Molecular Characterization of Breast Cancer Subtypes from Joint Analysis of High Throughput miRNA and mRNA Data (II) 111 16625
40 BREAST GSE2034 GSE2034 - Breast cancer relapse free survival 286 13480
41 BREAST GSE21653   GSE21653 - A gene expression signature identifies two prognostic subgroups of basal breast cancer 247 16523
42 BREAST GSE22133-GPL5345   GSE22133 - Genomic Subtypes of Breast Cancer Identified by Array Comparative Genomic Hybridization 349 5926
43 BREAST GSE22219   GSE22219 - Gene expression profiling of early primary breast cancer to identify prognostic markers and associated pathways 215 9867
44 BREAST GSE22226-GPL1708   GSE22226 - Heterogeneity of Response to Chemotherapy and Recurrence-free Survival in Neoadjuvant Breast Cancer: Results from the I-SPY 1 TRIAL 128 10354
45 BREAST GSE25055   GSE25055 - Discovery cohort for genomic predictor of response and survival following neoadjuvant taxane-anthracycline chemotherapy in breast cancer 309 12079
46 BREAST GSE25065   GSE25065 - Validation cohort for genomic predictor of response and survival following neoadjuvant taxane-anthracycline chemotherapy in breast cancer 197 12079
47 BREAST GSE2603 GSE2603 - Subpopulations of MDA-MB-231 and Primary Breast Cancers 82 13480
48 BREAST GSE2607-GPL1390   GSE2607 - Biological Classification of Breast Cancer by Real-Time Quantitative RTPCR: Comparisons to Microarray and Histopathology 47 5951
49 BREAST GSE2607-GPL887   GSE2607 - Biological Classification of Breast Cancer by Real-Time Quantitative RTPCR: Comparisons to Microarray and Histopathology 38 11863
50 BREAST GSE2990 GSE2990 - Gene Expression Profiling in Breast Cancer: Understanding the Molecular Basis of Histologic Grade To Improve Prognosis 101 13480
51 BREAST GSE3143   GSE3143 -Signatures of Oncogenic Pathway Deregulation in Human Cancers 157 8684
52 BREAST GSE3494_U133A GSE3494_U133A - An expression signature for p53 in breast cancer predicts mutation status, transcriptional effects, and patient survival 236 13480
53 BREAST GSE3494_U133B GSE3494_U133B - An expression signature for p53 in breast cancer predicts mutation status, transcriptional effects, and patient survival 236 9856
54 BREAST GSE37181   GSE37181 - Subtype-dependent prognostic relevance of an interferon-induced pathway metagene in human node negative breast cancer 122 14406
55 BREAST GSE37751 GSE37751 - Molecular Profiles of Human Breast Cancer and Their Association with Tumor Subtypes and Disease Prognosis (Affymetrix) 60 21093
56 BREAST GSE42568 GSE42568 - Breast Cancer Gene Expression Analysis 104 21703
57 BREAST GSE46563   GSE46563 - Prognostic value of gene signatures and proliferation in lymph node negative breast cancer 93 14406
58 BREAST GSE48390   GSE48390 - Concurrent Gene Signatures for Han Chinese Breast Cancers [Affymetrix] 80 16523
59 BREAST GSE48408 GSE48408 - Long non-coding RNA HOTAIR is an independent prognostic marker of metastasis in estrogen receptor positive primary breast cancer 164 21793
60 BREAST GSE4922_U133A GSE4922_U133A - Genetic Reclassification of Histologic Grade Delineates New Clinical Subtypes of Breast Cancer 249 13480
61 BREAST GSE4922_U133B GSE4922_U133B - Genetic Reclassification of Histologic Grade Delineates New Clinical Subtypes of Breast Cancer 248 9856
62 BREAST GSE53031   GSE53031 - Gene expression profiling of human breast cancer during pregnancy 166 17306
63 BREAST GSE5327 GSE5327 - Breast cancer relapse free survival and lung metastasis free survival 58 13480
64 BREAST GSE58812   GSE58812 - Gene-expression molecular subtyping of triple-negative breast cancer tumours: importance of immune response 106 16523
65 BREAST GSE6130-GPL1390   GSE6130 - Agreement in Breast Cancer Classification between Microarray and qRT-PCR from Fresh-Frozen and Formalin-Fixed Tissues 66 5568
66 BREAST GSE6130-GPL887   GSE6130 - Agreement in Breast Cancer Classification between Microarray and qRT-PCR from Fresh-Frozen and Formalin-Fixed Tissues 33 11720
67 BREAST GSE6532_U133_P2 GSE6532_U133_P2 - Definition of clinically distinct molecular subtypes in estrogen receptor positive breast carcinomas using genomic grade 87 21212
68 BREAST GSE6532_U133A GSE6532_U133A - Definition of clinically distinct molecular subtypes in estrogen receptor positive breast carcinomas using genomic grade 189 13480
69 BREAST GSE6532_U133B GSE6532_U133B - Definition of clinically distinct molecular subtypes in estrogen receptor positive breast carcinomas using genomic grade 126 9856
70 BREAST GSE7390 GSE7390 - Strong Time Dependence of the 76-Gene Prognostic Signature 198 13480
71 BREAST GSE9195 GSE9195 - Predicting prognosis using molecular profiling in estrogen receptor-positive breast cancer treated with tamoxifen 77 21212
72 BREAST GSE9893   GSE9893 - A gene expression signature predicting the recurrence of tamoxifen-treated primary breast cancer 154 7404
73 BREAST NKI NKI - A gene-expression signature as a predictor of survival in breast cancer 295 11475
74 BREAST TCGA-BRCA TCGA - TCGA BREAST CANCER DATA 596 17813
75 CERVICAL GSE44001 GSE44001 - Genetic profiling to predict recurrence of early cervical cancer 300 20669
76 CERVICAL TCGA-CESC   TCGA DATA CERVICAL SQUAMOUS CELL CARCINOMA AND ENDOCERVICAL ADENOCARCINOMA 281 17503
77 COLORECTAL GSE12945 GSE12945 - Expression data from colorectal cancers 62 13720
78 COLORECTAL GSE14333 GSE14333 - Expression data from 290 primary colorectal cancers 187 21703
79 COLORECTAL GSE16125 GSE16125 - Integrative approach for prioritizing cancer genes in sporadic colon cancer 32 14984
80 COLORECTAL GSE17536 GSE17536 - Metastasis Gene Expression Profile Predicts Recurrence and Death in Colon Cancer Patients 174 21212
81 COLORECTAL GSE17537 GSE17537- Metastasis Gene Expression Profile Predicts Recurrence and Death in Colon Cancer Patients 52 21212
82 COLORECTAL GSE24551 GSE24551 - Exon level expression profiling of colorectal cancer tissue samples 160 14984
83 COLORECTAL GSE28722 GSE28722 - EMT is the dominant program in human colon cancer (Agilent) 125 15218
84 COLORECTAL GSE28814 GSE28814 - EMT is the dominant program in human colon cancer 122 15240
85 COLORECTAL GSE29621 GSE29621 - mRNA and microRNA profile in colon cancer [mRNA data] 65 21703
86 COLORECTAL GSE30378 GSE30378 - Gene level expression profiling of colorectal cancer tissue samples (test sample series) 95 14984
87 COLORECTAL GSE31595 GSE31595 - Gene Expression Profiles in Stage II and III Colon Cancer. Application of a 128-gene signature 37 21703
88 COLORECTAL GSE38832   GSE38832 - NFAT transcriptional activity is associated with metastatic capacity in colon cancer 121 16523
89 COLORECTAL GSE39582   GSE39582 - Gene expression Classification of Colon Cancer 578 16523
90 COLORECTAL GSE41258 GSE41258 - Expression data from colorectal cancer patients 182 13720
91 COLORECTAL TCGA-COAD TCGA DATA COLON ADENOCARCINOMA 121 17813
92 ESOPHAGUS GSE19417 GSE19417 - Human esophageal adenocarcinomas 70 17367
93 ESOPHAGUS TCGA-ESCA   TCGA DATA ESOPHAGEAL CARCINOMA 180 18077
94 EYE GSE22138 GSE22138 - Expression Data from Uveal Melanoma primary tumors. 63 21703
95 EYE GSE39717 GSE39717 - Gene expression analysis of uveal melanoma tumor tissue 30 21454
96 EYE TCGA-UVM   TCGA DATA UVEAL MELANOMA 77 16577
97 GASTRIC GSE15459   GSE15459 - Gastric Cancer Project '08 (Singapore Patient Cohort) 186 16523
98 GASTRIC GSE26253   GSE26253 - Gene expression profiling of formalin fixed paraffin embedded tumor tissue identifies gastric cancer patients who are at high risk after curative surgery plus adjuvant chemoradiotherapy 431 11579
99 GASTRIC GSE34942   GSE34942 - Gastric cancer subtyping (Singapore Patient Cohort, batch B) 55 16523
100 GASTRIC GSE62254   GSE62254 - Molecular analysis of gastric cancer identifies discrete subtypes associated with distinct clinical characteristics and survival outcomes 299 16523
101 HEME GSE10846 GSE10846 - Prediction of survival in diffuse large B cell lymphoma treated with chemotherapy plus Rituximab 414 21703
102 HEME GSE12417_U133A GSE12417 - Prognostic gene signature for normal karyotype AML - Affy U133A Samples 163 13480
103 HEME GSE12417_U133B GSE12417 - Prognostic gene signature for normal karyotype AML - Affy U133B Samples 162 9856
104 HEME GSE12417_U133P2 GSE12417 - Prognostic gene signature for normal karyotype AML - Affy U133plus2 Samples 79 21212
105 HEME GSE16131_U133A Differences Between Follicular Lymphoma With and Without Translocation t(14;18) 180 13719
106 HEME GSE16131_U133B Differences Between Follicular Lymphoma With and Without Translocation t(14;18) 180 10686
107 HEME GSE22762_U133A An eight-gene expression signature for the prediction of survival and time to treatment in chronic lymphocytic leukemia 44 13719
108 HEME GSE22762_U133B An eight-gene expression signature for the prediction of survival and time to treatment in chronic lymphocytic leukemia 44 10684
109 HEME GSE22762_U133P2 An eight-gene expression signature for the prediction of survival and time to treatment in chronic lymphocytic leukemia 107 21703
110 HEME GSE23501 GSE23501 - DNA methylation signatures define molecular subtypes of Diffuse Large B Cell Lymphoma 69 21703
111 HEME GSE2658 GSE2658 - Gene Expression Profiles of Multiple Myeloma 546 21703
112 HEME GSE4475 GSE4475 - A Biologic Definition of Burkitt's Lymphoma from Transcriptional and Genomic Profiling 158 13719
113 HEME TCGA-AML TCGA DATA ACUTE MYELOID LEUKEMIA 157 21212
114 HNC GSE10300 GSE10300 - head and neck squamous cell carcinoma samples 43 21703
115 HNC GSE27020   GSE27020 - Identification and validation of a multigene predictor of recurrence in primary laryngeal cancer 108 12079
116 HNC GSE65858   GSE65858 - Gene expression patterns and TP53 mutations are associated with HPV RNA status, lymph node metastasis, and survival in head and neck cancer 269 14493
117 HNC TCGA HEAD AND NECK SQUAMOUS CELL CARCINOMA DATA 291 17187
118 HNC E-MTAB-1328 E-MTAB-1328 - Methylome, transcriptome and miRNome profiling by array and high throughput sequencing of 89 patients with head and neck squamous cell carcinoma 60 21703
119 LIVER GSE10141 GSE10141 - Gene Expression in Fixed Tissues and Outcome in Hepatocellular Carcinoma 80 6100
120 LIVER GSE17856 GSE17856 - Gene expression in nontumoral liver tissue and recurrence-free survival in hepatitis C virus-positive HCC 43 14293
121 LIVER GSE27150 GSE27150 - Transcriptional profile of human liver tissues: hepatocellular carcinoma vs. matched noncancerousliver tissue 81 2456
122 LIVER TCGA-LIHC   TCGA DATA LIVER HEPATOCELLULAR CARCINOMA 293 16873
123 LUNG GSE11117 GSE11117 - Molecular Classification and Prediction of Survival in Non-Small-Cell Lung Cancer 41 9601
124 LUNG GSE11969 GSE11969 - Expression Profile-Defined Classification of Lung Adenocarcinoma 90 16531
125 LUNG GSE13213 GSE13213 - Relapse-related molecular signature in lung adenocarcinomas identifies patients with dismal prognosis 117 30469
126 LUNG GSE14814 GSE14814 - Prognostic and Predictive Gene Signature for Adjuvant Chemotherapy in Resected Non-Small Cell Lung Cancer 88 13481
127 LUNG GSE17710 GSE17710 - Human lung squamous cell carcinoma expression profiling 56 17083
128 LUNG GSE19188 GSE19188 - Expression data for early stage NSCLC 82 21703
129 LUNG GSE26939 GSE26939 - Human lung adenocarcinoma mRNA expression and gene mutations 115 17108
130 LUNG GSE30219 GSE30219 - Off-context gene expression in lung cancer identifies a group of metastatic-prone tumors 282 21703
131 LUNG GSE31210 GSE31210 - Gene expression data for pathological stage I-II lung adenocarcinomas 226 21703
132 LUNG GSE3141 GSE3141 - Lung Cancer Dataset 111 21703
133 LUNG GSE37745 GSE37745 - Biomarker discovery in non-small cell lung cancer: integrating gene expression profiling, meta-analysis and tissue microarray validation 96 21703
134 LUNG GSE41271 GSE41271 - Expression profiling of 275 lung cancer specimens 275 25428
135 LUNG GSE42127 GSE42127 - Expression data for non-small-cell lung cancer 176 25428
136 LUNG GSE4573 GSE4573 - Gene expression signatures for predicting prognosis of squamous cell lung carcinomas 130 13480
137 LUNG GSE50081 GSE50081 - Validation of a histology-independent prognostic gene signature for early stage, non-small cell lung cancer including stage IA patients 181 21703
138 LUNG GSE5843 GSE5843 - Expression profiling defines a recurrence signature in lung adenocarcinoma 48 12089
139 LUNG GSE8894 GSE8894 - Prediction of Recurrence-Free Survival in Postoperative NSCLC Patients - a Useful Prospective Clinical Practice 138 21213
140 LUNG TCGA-LUAD TCGA DATA LUNG ADEMOCARCINOMA 150 20502
141 LUNG TCGA-LUSC TCGA DATA LUNG SQUAMOUS CELL CARCINOMA 120 17813
142 MESOTHELIOMA TCGA-MESO   TCGA DATA MESOTHELIOMA 85 17580
143 NEURO-ENDOCRINE GSE62564   GSE62564 - An Investigation of Biomarkers Derived from Legacy Microarray Data for Their Utility in the RNA-Seq Era 497 18440
144 NEURO-ENDOCRINE TCGA-PCPG   TCGA DATA PHEOCHROMOCYTOMA AND PARAGANGLIOMA 175 17374
145 OVARIAN GSE13876   GSE13876 - Survival Related Profile, Pathways and Transcription Factors in Ovarian Cancer 414 13462
146 OVARIAN GSE14764 GSE14764 - A Prognostic Gene Expression Index in Ovarian Cancer 79 13480
147 OVARIAN GSE17260 GSE17260 - Prediction of progression-free survival in patients with advanced-stage serous ovarian cancer 110 19566
148 OVARIAN GSE18520 GSE18520 - Whole-genome oligonucleotide expression analysis of papillary serous ovarian adenocarcinomas 53 21703
149 OVARIAN GSE19829_U133P2 GSE19829 - A gene expression profile of BRCAness that is associated with outcome in ovarian cancer. AffyU133plus2 Samples 26 21212
150 OVARIAN GSE19829_U95V2 GSE19829 - A gene expression profile of BRCAness that is associated with outcome in ovarian cancer. AffyU95v2 Samples 39 9383
151 OVARIAN GSE23554 GSE23554 - Ovarian Cancer Dataset 28 13719
152 OVARIAN GSE26712 GSE26712 - A Gene Signature Predicting for Survival in Suboptimally Debulked Patients with Ovarian Cancer 185 13480
153 OVARIAN GSE30161 GSE30161 - Genomic Multivariate Predictors of Response to Adjuvant Chemotherapy in Ovarian Carcinoma: Predicting Platinum Resistance 58 21703
154 OVARIAN GSE31245 GSE31245 - Unique gene expression profile based upon pathologic response in epithelial ovarian cancer 55 9651
155 OVARIAN GSE32062 GSE32062 - Immune-activation as a therapeutic direction for patients with high-risk ovarian cancer based on gene expression signature 260 19595
156 OVARIAN GSE32063 GSE32063 - Immune-activation as a therapeutic direction for patients with high-risk ovarian cancer based on gene expression signature (2) 40 19566
157 OVARIAN GSE49997 GSE49997 - Validating the Impact of a Molecular Subtype in Epithelial Ovarian Cancer (EOC) on Progression Free and Overall Survival 194 16726
158 OVARIAN GSE63885   GSE63885 - Gene expression profiling in ovarian cancer 74 16523
159 OVARIAN GSE73614   GSE73614 - Can High Grade Serous Ovarian Cancer TCGA Gene Expression Signatures be seen in High Grade Endometrioid or Clear Cell Ovarian Cancer? 106 15789
160 OVARIAN GSE8841   GSE8841 - ANALYSIS OF GENE EXPRESSION IN EARLY-STAGE OVARIAN CANCER 82 1415
161 OVARIAN GSE8842 GSE8842 - ANALYSIS OF GENE EXPRESSION IN EARLY-STAGE OVARIAN CANCER 78 5631
162 OVARIAN GSE9891 GSE9891 - Expression profile of 285 ovarian tumour samples 276 21212
163 OVARIAN TCGA-OVAD TCGA DATA OVARIAN ADENOCARCINOMA 578 12042
164 PANCREAS GSE21501 GSE21501 - A six-gene signature predicts survival of patients with localized pancreatic ductal adenocarcinoma 102 19680
165 PANCREAS GSE28735 GSE28735 - Microarray gene-expression profiles of 45 matching pairs of pancreatic tumor and adjacent non-tumor tissues from 45 patients with pancreatic ductal adenocarcinoma 42 21096
166 PANCREAS GSE50827   GSE50827 - ICGC Pancreas: Genomewide DNA methylation patterns in pancreatic ductal adenocarcinoma (gene expression of 103 samples) 32 16928
167 PANCREAS GSE57495   GSE57495 - Development of a prognostic gene signature in pancreatic cancer 63 17043
168 PANCREAS GSE71729   GSE71729 - Virtual Microdissection of Pancreatic Ductal Adenocarcinoma Reveals Tumor and Stroma Subtypes 124 15758
169 PANCREAS TCGA-PAAD   TCGA DATA PANCREATIC ADENOCARCINOMA 170 17997
170 PROSTATE GSE16560 GSE16560 - Molecular Sampling of Prostate Cancer: a dilemma for predicting disease progression 281 6100
171 PROSTATE GSE26022   GSE26022 - Protein-coding and MicroRNA Biomarkers of Recurrence of Prostate Cancer Following Radical Prostatectomy 70 472
172 PROSTATE GSE26242   GSE26242 - Protein-coding and MicroRNA Biomarkers of Recurrence of Prostate Cancer Following Radical Prostatectomy [Gene Expression Validation Set] 78 472
173 PROSTATE GSE40272 GSE40272 - Gene-expression profiling of prostate tumors 67 9371
174 PROSTATE GSE70768   GSE70768 - Prostate cancer stratification using molecular profiles 110 16928
175 PROSTATE GSE70769   GSE70769 - Prostate cancer stratification using molecular profiles 91 16930
176 PROSTATE TCGA-PRAD   TCGA DATA PROSTATE ADENOCARCINOMA 413 17682
177 RECTUM TCGA_READ TCGA DATA RECTAL ADENOCARCINOMA 42 17728
178 RENAL GSE29609 GSE29609 - Clear-cell renal cell carcinomas tumors 39 18841
179 RENAL TCGA-KIRC TCGA DATA KIDNEY CLEAR CELL CARCINOMA 528 20502
180 RENAL TCGA-KICH   TCGA DATA KIDNEY CHROMOPHOBE 66 17131
181 RENAL TCGA-KIRC   TCGA DATA KIDNEY RENAL CLEAR CELL CARCINOMA 234 17652
182 RENAL TCGA-KIRP   TCGA DATA KIDNEY RENAL PAPILLARY CELL CARCINOMA 220 17357
183 SARCOMA TCGA-SARC   TCGA DATA SARCOMA 234 17382
184 SKIN GSE19234 GSE19234 - Immune profile and mitotic index of metastatic melanoma lesions enhance clinical staging in predicting patient survival. 44 21703
185 SKIN GSE22153 GSE22153 - Gene Experssion Profiling-Based Identification of Molecular Subtypes in Stage IV Melanoma with Different Clinical Outcome (test set) 57 24614
186 SKIN GSE53118 GSE53118 - BRAF Mutation, NRAS Mutation, and the Absence of an Immune-Related Expressed Gene Profile Predict Poor Outcome in Patients with Stage III Melanoma 79 17617
187 SKIN TCGA-SKCM TCGA SKIN CUTANEOUS MELANOMA DATA 163 15341
188 STOMACH TCGA-STAD TCGA DATA STOMACH ADENOCARCINOMA 18 20512
189 THYMUS TCGA-THYM   TCGA DATA THYMOMA 119 17652
190 THYROID TCGA-THCA   TCGA DATA THYROID CARCINOMA 476 17410
191 UTERUS TCGA-UTED TCGA DATA UTERINE ENDOMETRIAL CARCINOMA 54 17813
192 UTERUS TCGA-UCEC   TCGA DATA UTERINE CORPUS ENDOMETRIAL CARCINOMA 143 17620
193 UTERUS TCGA-UCS   TCGA DATA UTERINE CARCINOSARCOMA 55 18011